Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × entinostat × Clear all

NCT03978624 2025-10-15

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Phase 2 Active not recruiting

20 enrolled 11 charts

Urinary Bladder Neoplasms